Investors are reassessing expectations for an Anthropic initial public offering, while Germany is moving to take a 50% stake in tank maker KNDS, according to the latest Bloomberg deals coverage.
Corporate finance · Deals roundup
Three deals, three open questions: Anthropic's IPO, Germany's KNDS stake, and CVS's spinoff
Investors are reassessing Anthropic's IPO valuation hopes, Germany is moving to take half of tank maker KNDS, and analysts question whether CVS's planned spinoff will fix its growth. All three developments are early, and key terms remain unconfirmed.
50%
Share of KNDS that Germany plans to buy
3
Separate corporate finance developments covered
Unconfirmed
Anthropic valuation range and timing
KNDS: planned state stake, drawn to scale
Each column is 10 blocks = 100% of KNDS. Filled blocks show the share Germany plans to acquire.
A half stake would give the German state a major role in a company central to European military equipment supply. Price, seller and closing conditions have not been specified.
Anthropic IPO
Investors may pay less than earlier hopes for the AI company.
Watched by AI developers planning public listings, since it shapes how markets price compute-heavy frontier model businesses.
KNDS stake
Part of a wider European trend of governments expanding in defense manufacturing.
Open question: whether Berlin gains influence over production priorities and export decisions.
CVS spinoff
Analysis questions whether breakups deliver faster growth.
Outcome depends on execution and on the operating performance of each resulting company.
Continue reading The rest of this article is for AI News Blitz readers. Choose an option below to keep reading.
Already purchased? Sign in ✓ Signed in — this article isn’t included in your current plan.Unlocking the full article...